← Mechanisms of action
INS
SINGLE PROTEINHomo sapiens
Preferred name: Insulin ChEMBL ↗
Linked proteins
Drugs acting on this target (10)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bht-3021 | Immunity, desensitized | experimental | Gene therapy | INS immunity, desensitized |
| c19-a3 gnp | Immunity, desensitized | experimental | Vaccine | INS immunity, desensitized |
| ibc-vs01 | Immunity, desensitized | experimental | Vaccine | INS immunity, desensitized |
| mas-1 adjuvanted insulin b-chain | Immunity, desensitized | experimental | Vaccine | INS immunity, desensitized |
| monoclonal antibody 3a1 | Inhibitor | experimental | mAb | INS inhibitor |
| xoma 358 | Inhibitor | experimental | mAb | INS inhibitor |
| nnc0361-0041 | Modulator | experimental | Gene therapy | INS modulator |
| c-peptide | Supplementation | experimental | Peptide | INS supplementation |
| insulin human (humulin) | Supplementation | approved | Recombinant protein | INS supplementation |
| insulin producing stem cells | Supplementation | experimental | Cell therapy | INS supplementation |